8 Jun 2012
GLYCOTOPE moves FSH-GEX™ into Phase-II Clinical Development
Read press release
19 Sep 2011
Glycotope Enrolls First Patients in Phase I Trial with TrasGEX™, a Glycooptimized HER2 Biobetter Antibody
Read press release
18 May 2011
Glycotope Enrolls First Patients in Phase I Trial for FSH-GEX™
Read press release